Related Experiment Video
Updated: May 9, 2026

Quantitative Fundus Autofluorescence for the Evaluation of Retinal Diseases
Published on: March 11, 2016
Validation of Automated Software for Guttae Quantification in Fuchs Endothelial Corneal Dystrophy.
Simran R Sarin1, Jérôme Abou Assi2, Jessica M Skeie1,3
1Department of Ophthalmology and Visual Sciences, University of Iowa Carver College of Medicine, Iowa City, IA, USA.
A new automated software accurately quantifies corneal guttae area ratio (GAR) in Fuchs endothelial corneal dystrophy (FECD) images, matching expert grading. This tool enables objective measurement of FECD progression and treatment effectiveness.
Area of Science:
- Ophthalmology
- Medical Imaging
- Computational Pathology
Background:
- Corneal guttae are characteristic of Fuchs endothelial corneal dystrophy (FECD).
- Accurate quantification tools are needed for advancing FECD therapies.
- Automated analysis of guttae and their progression is crucial for patient management.
Purpose of the Study:
- To develop and validate a novel automated software platform for quantifying the guttae area ratio (GAR) in FECD specular microscopy images.
- To compare automated GAR measurements with expert manual grading.
- To assess the correlation between automated GAR and FECD disease severity and subclinical edema.
Main Methods:
- Prospective enrollment of FECD patients (mKg 2-5) without prior keratoplasty.
- Specular microscopy imaging and Scheimpflug imaging for subclinical edema assessment.
- Validation study comparing automated GAR with manual expert grading and correlating GAR with disease grade.
Main Results:
- Automated GAR demonstrated equivalence to manual expert grading (P = 0.003).
- Automated GAR significantly increased with worsening FECD disease severity (mKg 2-5).
- High repeatability of GAR measurements was observed (intraclass correlation = 0.85).
Conclusions:
- Automated software for guttae quantification in FECD is validated and equivalent to manual grading.
- Automated GAR is an objective metric that correlates with disease severity and may precede subclinical edema.
- This software enables precise, objective measurement of FECD progression and therapeutic efficacy.
More Related Videos
12:36A Human Corneal Organ Culture Model of Descemet's Stripping Only with Accelerated Healing Stimulated by Engineered Fibroblast Growth Factor 1
Published on: July 22, 2022
08:54A Workflow to Quantitatively Determine Age-Related Macular Degeneration Lesion-Specific Variations in Fundus Autofluorescence
Published on: May 26, 2023